Abstract:Connective tissue disorders (CTDs) involve multiple organ systems and may have a significant impact on the overall health and quality of life of the affected individuals. The present paper aims to review the current knowledge on the laryngeal manifestations of CDTs, and describe the available diagnostic and treatment options. Systematic literature review in Medline and other database sources. Information from related books was also included. Prospective controlled, double-blind prospective, prospective, and tr… Show more
“…Inconsistent conclusions have been drawn regarding whether patients with autoimmune disease are predisposed to epiglottitis, 25 and studies investigating the autoimmune disease-epiglottitis relationship are limited. [12][13][14]16,17,26 Based on our literature review, the present research is the first populationbased study on the epiglottitis-autoimmune disease association.…”
Objectives: The role of autoimmune diseases on the risk for acute epiglottitis remains uncertain. This study aimed to delineate the association between epiglottitis and autoimmune diseases using population database. Methods: A population-based retrospective study was conducted to analyze claims data from Taiwan National Health Insurance Research Database collected over January, 2000, to December, 2013. Results: In total, 2339 patients with epiglottitis were matched with 9356 controls without epiglottitis by sex, age, socioeconomic status, and urbanization level. The correlation between autoimmune diseases and epiglottitis was analyzed by multivariate logistic regression. Compared with controls, patients with epiglottitis were much more likely to have preexisting Sjögren syndrome (adjusted odds ratio [aOR]: 2.37; 95% CI: 1.14-4.91; P = .021). In addition, polyautoimmunity was associated with increased risk of epiglottitis (aOR: 2.08; 95% CI: 1.14-3.80; P = .018), particularly in those aged >50 years (aOR: 2.61; 95% CI: 1.21-5.66; P = .015). Conclusions: Among autoimmune diseases, we verify the association between epiglottitis and Sjögren syndrome in Taiwan. Furthermore, we present the novel discovery that patients with epiglottitis have an increased risk of polyautoimmunity, particularly those aged >50 years.
“…Inconsistent conclusions have been drawn regarding whether patients with autoimmune disease are predisposed to epiglottitis, 25 and studies investigating the autoimmune disease-epiglottitis relationship are limited. [12][13][14]16,17,26 Based on our literature review, the present research is the first populationbased study on the epiglottitis-autoimmune disease association.…”
Objectives: The role of autoimmune diseases on the risk for acute epiglottitis remains uncertain. This study aimed to delineate the association between epiglottitis and autoimmune diseases using population database. Methods: A population-based retrospective study was conducted to analyze claims data from Taiwan National Health Insurance Research Database collected over January, 2000, to December, 2013. Results: In total, 2339 patients with epiglottitis were matched with 9356 controls without epiglottitis by sex, age, socioeconomic status, and urbanization level. The correlation between autoimmune diseases and epiglottitis was analyzed by multivariate logistic regression. Compared with controls, patients with epiglottitis were much more likely to have preexisting Sjögren syndrome (adjusted odds ratio [aOR]: 2.37; 95% CI: 1.14-4.91; P = .021). In addition, polyautoimmunity was associated with increased risk of epiglottitis (aOR: 2.08; 95% CI: 1.14-3.80; P = .018), particularly in those aged >50 years (aOR: 2.61; 95% CI: 1.21-5.66; P = .015). Conclusions: Among autoimmune diseases, we verify the association between epiglottitis and Sjögren syndrome in Taiwan. Furthermore, we present the novel discovery that patients with epiglottitis have an increased risk of polyautoimmunity, particularly those aged >50 years.
“…Oropharyngeal or nasal involvement (ulcerations) is noted in 90% of patients and is included in the diagnostic criteria [7]; more rarely other manifestations may be noted such as trigeminal neuralgia, facial nerve involvement, vocal cord palsy or specific laryngeal involvement and hearing abnormalities [4,7,47,55,56]. The disease is due to a lymphocytic infiltration of the exocrine glands, mainly salivary and lacrimal, causing a drying up of their secretions [57].…”
Section: Systemic Lupus Erythematosusmentioning
confidence: 99%
“…Oropharyngeal mucosal involvement and cervical polyadenopathy are among the diagnostic criteria for Kawasaki disease [55], and perforations of the nasal septum can be seen in cryoglobulinemia and the primary antiphospholipid syndrome [22].…”
Systemic Vasculitis
GPA, Formerly Wegener's DiseaseGPA is a very rare disease, classified as a systemic necrotizing vasculitis and is characterized by granulomatous inflammation of the wall of small vessels and the presence in patients' serum of autoantibodies directed against the cytoplasm of neutrophils (ANCA) with cytoplasmic enhancement in indirect
“…Fakultativ kann auch eine extraartikuläre Organmanifestation vorliegen. Eine laryngeale Beteiligung wird bei bis zu 75 % der Patienten beschrieben [12]. Am Larynx können entweder eine Arthritis des Cricoarytenoidgelenks (CA-Gelenk), oder Rheumaknoten in der Schleimhaut bzw.…”
Rheumatic disorders (rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus, Wegener's granulomatosis, relapsing polychondritis) may affect the larynx. The clinical symptoms are often unspecific, leading to delayed diagnosis. Malignant tumours should be considered in differential diagnosis with necessitating biopsy. Treatment may require interdisciplinary approach together with a specialist in internal medicine and rheumatology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.